CVRx, Inc.
CVRx, Inc. (CVRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CVRX · as of Jun 9, 2026
Key Statistics
Explore CVRx, Inc. Data
cvrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The CVRX analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +85.19% upside from the current price of $5.40.
Competitors & Peers
cvrx competitorsCVRX
CERS
MASS
NNOX
OMI
PRQRStock Performance
Full HistoryAbout CVRx, Inc.
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases…
what is cvrx, inc. · cvrx stock overview · cvrx, inc. company profile · who is cvrx, inc. ceo · cvrx NASDAQ · cvrx, inc. headquarters · cvrx, inc. business segments
About Stock Overview & Key Data
CVRx, Inc. (CVRX) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jun 30, 2021. As of the latest trading session, CVRX stock price is $5.40, with a market capitalization of $143.3M. The stock has returned -13.32% over the past 12 months and -23.94% year-to-date.
According to 7 Wall Street analysts, the consensus rating for CVRx, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, CVRx, Inc. reported revenue of $56.7M and net income of -$53.3M. For detailed data — including CVRx, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CVRx, Inc. (CVRX) stock price is $5.40. The stock is traded on NASDAQ under the ticker symbol CVRX. The 52-week range is $4.37 – $11.30.